{
    "organizations": [],
    "uuid": "166ae5edb0054d7693f7bf3139705e155912b35e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sorrento-therapeutics-announces-un/brief-sorrento-therapeutics-announces-unsecured-120-5m-convertible-note-financing-idUSASC09TRS",
    "ord_in_thread": 0,
    "title": "BRIEF-Sorrento Therapeutics Announces Unsecured $120.5M Convertible Note Financing",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Sorrento Therapeutics Inc:\n* SORRENTO THERAPEUTICS ANNOUNCES UNSECURED $120.5M CONVERTIBLE NOTE FINANCING\n* SORRENTO THERAPEUTICS-NOTES WILL BE CONVERTIBLE INTO SHARES OF SORRENTO COMMON STOCK AT $7.0125 PER SHARE AND ACCRUE INTEREST AT A RATE OF 5% PER YEARâ€‹ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ",
    "published": "2018-03-27T20:03:00.000+03:00",
    "crawled": "2018-03-28T19:04:29.036+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "sorrento",
        "therapeutic",
        "inc",
        "sorrento",
        "therapeutic",
        "announces",
        "unsecured",
        "convertible",
        "note",
        "financing",
        "sorrento",
        "convertible",
        "share",
        "sorrento",
        "common",
        "stock",
        "per",
        "share",
        "accrue",
        "interest",
        "rate",
        "per",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}